TOPVISION EYE SPECIALIST BERHAD
Last Price: 0.725
TTM Dividend Yield : 2.21%
Coming Quarter Report: ~ 2024-02-27
Yahoo Google Bursa Web TradingView
Sector: Healthcare Providers & Services
TOPVISION Eye Specialist Bhd is a Malaysia-based eyecare company. The Company offers eyecare services ranging from general eyecare and evaluation to treatment of complex eye diseases, such as vitreoretinal surgeries. It has over five eye specialist centers in Selangor and Johor.
**Do feedback to us if you see any error on the data
**Data before 2015 may not be accurate
**Dividend Yield calculated base on the last price of the year
TOPVISN Dividend Yield Trend
TOPVISN Quarter DY Yield
TOPVISN Annual DY Yield
TOPVISN Quarter Report History
TOPVISN Quarter Profit Trend
TOPVISN Annual Profit Trend
Cash Flow
In financial accounting, operating cash flow (OCF), cash flow provided by operations, cash flow from operating activities (CFO) or free cash flow from operations (FCFO), refers to the amount of cash a company generates from the revenues it brings in, excluding costs associated with long – term investment  on capital items or investment in securities.(From Wiki)
TOPVISN Annual Cash Flow
Â
ROE & Payout Ratio
Return on equity (ROE) is a measure of financial performance calculated by dividing net income by shareholders’ equity. Because shareholders’ equity is equal to a company’s assets minus its debt, ROE is considered the return on net assets. ROE is considered a measure of the profitability of a corporation in relation to stockholders’ equity. (From Investopedia)
The payout ratio is a financial metric showing the proportion of earnings a company pays its shareholders in the form of dividends, expressed as a percentage of the company’s total earnings. On some occasions, the payout ratio refers to the dividends paid out as a percentage of a company’s cash flow. The payout ratio is also known as the dividend payout ratio. (From Investopedia)
Topvision Eye Specialist Bhd operates eye specialist centre which provides eye care and treatment. It offers modern and advacnce treatments for both general and complex eye diseases.